ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
恆瑞醫藥
78.800
+3.450
4.58%
手動刷新
成交量：
531.56萬
成交額：
4.12億
市值：
5,229.96億
市盈率：
72.09
高：
79.000
開：
75.650
低：
75.500
收：
75.350
52周最高：
87.800
52周最低：
52.500
股本：
66.37億
香港流通股本：
2.58億
量比：
1.54
換手率：
2.06%
股息：
0.22
股息率：
0.28%
每股收益(LYR):
1.093
淨資產收益率：
15.22%
總資產收益率：
8.99%
市淨率：
10.18
市盈率(LYR):
72.09
市銷率:
16.39
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字：
恆瑞醫藥
交易所：
SEHK
成立時間：
1970
員工人數：
20238
公司地址：
No. 38, Huanghe Road,Economic and Technological Development Zone,Lianyungang City,Jiangsu Province,China
官網：
http://www.hrs.com.cn
郵編：
222000
電話：
86 40 0828 3900
傳真：
- -
簡介：
江蘇恆瑞醫藥股份有限公司是一家主要從事藥品的研發、生產和銷售的中國公司。該公司專註於腫瘤領域，覆蓋激酶抑製劑、抗體偶聯藥物（ADC）、腫瘤免疫、激素受體調控、脫氧核糖核酸（DNA）修復及表觀遺傳、支持治療等研究領域。該公司的產品包括抗腫瘤、鎮痛麻醉和造影劑，應用於自身免疫疾病、代謝性疾病、心血管疾病、感染疾病、呼吸系統疾病、血液疾病、疼痛管理、神經系統疾病、眼科、腎病等領域。該公司主要在國內外市場開展其業務。
董事
名稱
職位
孫飄揚
董事長，董事，戰略委員會主任委員，戰略委員會委員，提名委員會委員
戴洪斌
副董事長，董事，戰略委員會委員，薪酬與考核委員會委員
董家鴻
獨立董事，戰略委員會委員，提名委員會主任委員，提名委員會委員，審計委員會委員
曾慶生
獨立董事，薪酬與考核委員會委員，審計委員會主任委員，審計委員會委員
孫金雲
獨立董事，薪酬與考核委員會主任委員，薪酬與考核委員會委員，提名委員會委員
周紀恩
獨立董事
張連山
董事，戰略委員會委員
孫傑平
董事，審計委員會委員
郭叢照
董事，戰略委員會委員
江寧軍
董事，授權代表，戰略委員會委員
馮佶
董事，首席運營官
袁開紅
監事會主席，監事
熊國強
監事
徐煜
職工監事
田飛
證券事務代表
劉笑含
聯席公司秘書
梁穎嫻
聯席公司秘書，授權代表
股東
名稱
職位
馮佶
總經理
孫傑平
高級副總裁
劉健俊
財務總監
劉笑含
董事會秘書
張連山
執行副總裁
江寧軍
執行副總裁
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/01276/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"恆瑞醫藥","latestPrice":78.8,"timestamp":1755072507002,"preClose":75.35,"halted":0,"volume":5315607,"delay":0,"floatShares":258000000,"shares":6637000000,"eps":1.0929993405972305,"marketStatus":"未開盤","change":3.45,"latestTime":"08-13 16:08:27","open":75.65,"high":79,"low":75.5,"amount":411925367,"amplitude":0.04645,"askPrice":78.8,"askSize":4200,"bidPrice":78.6,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":1.192924619312651,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1755135000000},"marketStatusCode":0,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":75.35,"dividendRate":0.002777,"openAndCloseTimeList":[[1755048600000,1755057600000],[1755061200000,1755072000000]],"volumeRatio":1.5438738298149535,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"恆瑞醫藥","latestPrice":62.61,"timestamp":1755068400000,"preClose":60.85,"halted":0,"volume":81529600,"delay":0,"premium":"+15.15"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"8.99%","roe":"15.22%","lyrEps":1.093038,"volumeRatio":1.5438738298149535,"shares":6637000000,"dividePrice":0.218608,"high":79,"amplitude":0.04645,"preClose":75.35,"low":75.5,"week52Low":52.5,"pbRate":"10.18","psRate":"16.39","week52High":87.8,"institutionHeld":0,"latestPrice":78.8,"committee":-0.555556,"eps":1.0930378604118096,"divideRate":0.002774,"volume":5315607,"delay":0,"ttmEps":1.1929666607242386,"open":75.65,"prevYearClose":44.05,"prevWeekClose":76.7,"prevMonthClose":78.85,"prevQuarterClose":53.8,"fiveDayClose":80.5,"twentyDayClose":70.25,"sixtyDayClose":44.05,"earningDate":1755705600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2025-08-21","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755739800000,"name":null,"time":"","dateTimestamp":1755705600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2609,"buy":0.5217,"hold":0.1739,"sell":0.0435,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5217,"analysts":23,"updateTime":1753891200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2025-08-12","current":59.301536,"percent":0.807018,"low":50.027905,"twenty":51.20697,"median":53.257003,"eighty":58.489831,"high":62.270337,"avg":54.51388,"sd":3.613657,"marketCap":443360749310.36},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-12","current":59.301536,"twenty":51.20697,"median":53.257003,"eighty":58.489831,"marketCap":443360749310.36}],"updateTime":1755106676736},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6153489,"yearFounded":1970,"employeeNum":20238,"address":"No. 38, Huanghe Road,Economic and Technological Development Zone,Lianyungang City,Jiangsu Province,China","zipCode":"222000","officePhone":"86 40 0828 3900"},"stockCompanyDetail":{"websiteUrl":"http://www.hrs.com.cn","stockEarnings":[{"period":"1week","weight":-0.0698},{"period":"1month","weight":0.0436},{"period":"3month","weight":0.7106},{"period":"ytd","weight":0.7106}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":0.0344},{"period":"3month","weight":0.0562},{"period":"6month","weight":0.1446},{"period":"1year","weight":0.4592},{"period":"ytd","weight":0.2448}],"compareStock":{"symbol":"HSI","name":"恆生指數"},"description":"江蘇恆瑞醫藥股份有限公司是一家主要從事藥品的研發、生產和銷售的中國公司。該公司專註於腫瘤領域，覆蓋激酶抑製劑、抗體偶聯藥物（ADC）、腫瘤免疫、激素受體調控、脫氧核糖核酸（DNA）修復及表觀遺傳、支持治療等研究領域。該公司的產品包括抗腫瘤、鎮痛麻醉和造影劑，應用於自身免疫疾病、代謝性疾病、心血管疾病、感染疾病、呼吸系統疾病、血液疾病、疼痛管理、神經系統疾病、眼科、腎病等領域。該公司主要在國內外市場開展其業務。","exchange":"SEHK","name":"恆瑞醫藥","nameEN":"HENGRUI PHARMA"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":{"directors":[{"name":"孫飄揚","position":"董事長，董事，戰略委員會主任委員，戰略委員會委員，提名委員會委員"},{"name":"戴洪斌","position":"副董事長，董事，戰略委員會委員，薪酬與考核委員會委員"},{"name":"董家鴻","position":"獨立董事，戰略委員會委員，提名委員會主任委員，提名委員會委員，審計委員會委員"},{"name":"曾慶生","position":"獨立董事，薪酬與考核委員會委員，審計委員會主任委員，審計委員會委員"},{"name":"孫金雲","position":"獨立董事，薪酬與考核委員會主任委員，薪酬與考核委員會委員，提名委員會委員"},{"name":"周紀恩","position":"獨立董事"},{"name":"張連山","position":"董事，戰略委員會委員"},{"name":"孫傑平","position":"董事，審計委員會委員"},{"name":"郭叢照","position":"董事，戰略委員會委員"},{"name":"江寧軍","position":"董事，授權代表，戰略委員會委員"},{"name":"馮佶","position":"董事，首席運營官"},{"name":"袁開紅","position":"監事會主席，監事"},{"name":"熊國強","position":"監事"},{"name":"徐煜","position":"職工監事"},{"name":"田飛","position":"證券事務代表"},{"name":"劉笑含","position":"聯席公司秘書"},{"name":"梁穎嫻","position":"聯席公司秘書，授權代表"}],"executives":[{"name":"馮佶","position":"總經理"},{"name":"孫傑平","position":"高級副總裁"},{"name":"劉健俊","position":"財務總監"},{"name":"劉笑含","position":"董事會秘書"},{"name":"張連山","position":"執行副總裁"},{"name":"江寧軍","position":"執行副總裁"}]}}}